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Relation between impedance and endocardial 
contact during radiofrequency catheter 
ablation 
Lesion size during radiofrequency catheter ablation in patients with paroxysmal supraventricular 
tachycardia (PSVT) is thought to be related to multiple factors, including contact pressure at the 
catheter-endocardial interface. Therefore a predictor of contact pressure at a potential target site 
for ablation might be useful. In this study 25 patients underwent duplicate 2 W applications of 
radiofrequency energy with the catheter in poor and firm contact with the right ventricular 
endocardium after successful ablation treatment for PSVT. The mean age of the patients was 
44 + 15 years. Fifteen patients underwent slow pathway ablation for atrioventricular nodal 
reentrant tachycardia, and 10 patients underwent ablation for an accessory pathway. The mean 
impedance for low-energy applications in firm contact (139 k 24 ohms) was 22% f  13% greater 
(p 0.0001) than in poor contact with the right ventricle (113 k 16 ohms). The maximum impedance 
was 27% greater when the catheter was in firm (147 + 26 ohms) rather than poor contact 
(116 k 16 ohms), with the endocardium (p 0.0001). These results suggest that higher impedance 
measurements may be obtained with low-energy applications of 2 W when the ablation catheter 
is in firm contact with the endocardium. (AM HEART J 1994;126:226-9.) 
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The efficacy rates are high, but multiple applications 
are required and the procedure can be protracted. 
Experiments in animals have demonstrated a direct 
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Table I. Results 
Catheter-endocardial Mean impedance Maximum impedance 
contact (ohm) (ohms) 
Contact 1 
Poor 114 + 16 117 i- 16 
Firm 141 k 26* 150 c 30* 
Contact 2 
Poor 112 * 18 114 -+ 17 
Firm 134 + 21t 142 k 25t 
All poor contact applications 113 + 16 116 + 16 
All firm contact applications 139 k 24$ 147 + 281: 
*Significantly different from poor catheter-endocardial contact 1 (p 0.0001). 
tsignificantly different from poor catheter-endocardial contact 2 (p < O.OOlL 
$Significsntly different from all applications with poor catheter-endocardial contact (p 0.0001). 
correlation between catheter-endocardial contact 
pressure and lesion volume.5-6 Therefore some inef- 
fective applications may be the result of poor en- 
docardial contact. Predicting the adequacy of cathe- 
ter-endocardial contact before attempted lesion for- 
mation would be useful. Measured impedance during 
delivery of very low-power radiofrequency energy 
may be such a marker of tissue contact. The purpose 
of this study was to prospectively determine the 
magnitude of impedance change during a very low 
power application of radiofrequency energy as a 
function of endocardial contact. The usefulness of 
this technique for assessing endocardial contact will 
be discussed. 
METHODS 
Patient population. Twenty-five consecutive patients 
undergoing radiofrequency catheter ablation for paroxys- 
mal supraventricular tachycardia were included in the 
study. Slow pathway ablation was performed in 15 patients 
referred for treatment of typical atrioventricular nodal re- 
entrant tachycardia (AVNRT). The remaining 10 patients 
had ablation of accessory atrioventricular pathways. The 
mean age was 44 + 15 years, and 14 of the 25 patients were 
women. All patients were free of structural heart disease or 
chronic obstructive pulmonary disease. 
Catheter ablation procedure. A 7F steerable electrode 
catheter with a distal electrode 4 mm in length (Mansfield 
Scientific, Mansfield, Mass.) was used in all 25 patients. 
‘Techniques for positioning the ablation catheter have been 
described previously. l-3 The power source used in this 
study supplied a continuous, unmodulated output at 500 
KHz (EP Technologies, Inc., Mountain View, Calif.). Cur- 
rent was applied between the distal electrode of the abla- 
tion catheter and a large-diameter skin electrode placed on 
the posterior chest. Through an interface with a micro- 
computer (T-1600, Toshiba Electronics, Tokyo, Japan), 
this device measures and stores applied power and imped- 
ance during each application of radiofrequency energy. Af- 
ter successful ablation of either the slow pathway in 
patients with AVNRT or the accessory pathway, patients 
underwent the investigational protocol. 
Experimental protocol. Informed consent was obtained 
from all patients under a protocol approved by the Human 
Research Committee at the University of Michigan. In each 
patient the ablation catheter was introduced into the right 
ventricle. Under fluoroscopic guidance it was slowly with- 
drawn until it was no longer in consistent contact with the 
endocardium as manifested by sliding of the tip during the 
cardiac cycle. The absence of consistent contact was con- 
firmed by the observation of a bipolar capture threshold 
> 3.0 V (2 msec pulse width). A bipolar electrogram was 
recorded with minimal filtering (0.05 to 1000 Hz). To mea- 
sure impedance without producing a lesion, 2 W of radio- 
frequency power was applied for 30 seconds. Previous 
studies in animals have shown that applications at this 
output do not result in detectable injury.‘, s The catheter 
was then repositioned in firm contact with the right 
ventricular endocardium, as defined by a capture threshold 
5 1.0 V. As before, a bipolar electrogram was recorded. 
Two watts of radiofrequency power was again applied for 
30 seconds, and impedance was measured. To assess the 
reproducibility of this measurement and to determine 
whether there was a time-dependent factor that could in- 
fluence it, the protocol was repeated a second time in each 
patient. 
Statistical analysis. Continuous variables are expressed 
as mean i SD and were compared with Student’s t test for 
paired or unpaired variables. Probability values < 0.05 
were considered statistically significant. 
RESULTS 
Electrogram characteristics. The ventricular elec- 
trograms were 2.4 times larger when the catheter was 
in firm endocardial contact rather than in poor 
endocardial contact O-, 0.0001; Table I). For applica- 
tions in firm contact with the right ventricular 
endocardium, the mean ST-segment elevation was 
3 + 2 mV and the mean ventricular capture thresh- 
old was 0.6 f 0.2 mV (Fig. 1). 
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Fig. 1. Patient 7. Top, ventricular electrogram with catheter in poor contact with right ventricle. Note 
ventricular electrogram is 0.6 mV in amplitude and absence of ST-segment elevation. Bottom, ablation 
catheter in firm contact with endocardium of right ventricle. Ventricular electrogram is 9 mV in height with 
7 mV of ST-segment elevation. 
Impedance measurements. The impedance was 
25 + 15 ohms (22% + 13%) greater when the cath- 
eter was firmly in contact with the right ventricle 
(139 & 24 ohms) rather than in poor contact 
(113 & 16 ohms, p 0.0001; Table I). Likewise, the 
maximum impedance for applications in firm contact 
with the right ventricle were 27% greater than for 
applications with poor catheter-endocardial contact 
(p 0.0001). 
Reproducibility of electrogram and impedance data. 
There was no significant difference in the ventricular 
electrogram data or impedance data (Table I) be- 
tween the first and second applications of 2 W of ra- 
diofrequency energy when the catheter was in either 
firm or poor contact with the endocardium. 
DISCUSSION 
Main findings. These are the first data to demon- 
strate that firm catheter-tissue contact is an impor- 
tant determinant of impedance in human beings 
when very low-power radiofrequency energy is ap- 
plied to the right ventricular endocardium. The 
measured impedance is 22% greater when the abla- 
tion catheter is in firm contact with the endocardial 
surface rather than poor contact. 
Comparison with previous studies. Previous investi- 
gation in human beings has demonstrated that body 
surface area and forced vital capacity are important 
determinants of impedance during applications of 
radiofrequency energy. g Experiments in animalslO 
and studies in human beingsll have shown an early 
decrease in impedance as heating occurs at the cath- 
eter-endocardial interface. No previous study in an- 
imals or human beings has demonstrated an associ- 
ation between catheter-tissue contact pressure and 
measured impedance, although the present study in- 
dicates that impedance when the catheter has poor 
endocardial contact may relate to the resistivity of 
blood versus muscle; the resistivity of blood being 
less than muscle.12 Therefore the impedance of 
applications with poor endocardial contact would be 
more affected by the blood pool and, as was observed 
in the present study, would be expected to have a 
lower impedance. 
Limitations. This study characterized the effects of 
firm versus poor tissue contact only. Catheter contact 
pressure obtained for ablation of PSVT is usually as- 
sociated with the catheter in intermediate contact 
pressure with the endocardium. Additionally, these 
data were not obtained from potential target sites for 
ablation of PSVT; hence they may not predict the 
magnitude of change observed with low-power appli- 
cations of radiofrequency energy in the ventricular 
cavity and at potential target sites for ablation of 
PSVT. 
Clinical implications. Impedance monitoring has 
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previously been shown to be an effective way to pre- 
dict tissue heating during applications of radiofre- 
quency energy for ablation of PSVT.g These data 
suggest that measured impedance is greater by about 
20 ‘3% when there is firm catheter-endocardial contact 
as opposed to poorer tissue contact. Contact pressure 
may be predicted by comparing the change in ob- 
served impedance where a 2 W application of radio- 
frequency energy is applied in the ventricular cavity 
and then to a potential target site. Because contact 
pressure is a predictor of lesion size,” impedance 
monitoring during low-energy applications at poten- 
tial target sites may be able to predict sites with 
greater contact pressure and therefore decrease the 
applications of radiofrequency energy at sites with 
poor tissue contact. This could lead to a shorter pro- 
cedure duration and fewer applications of radiofre- 
quency energy. However, the relationship between 
tissue contact and impedance at target sites for ab- 
lation of PSVT requires further investigation. 
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